Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-04-11 @ 7:02 AM
Study NCT ID:
NCT06733051
Status:
RECRUITING
Last Update Posted:
2025-02-10
First Post:
2024-12-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)
Sponsor:
Sun Yat-sen University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
B2024-736-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None